Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q3 2020 · 10-Q
Revenue—
Net Income-$4.50M-$4.50MN/M vs Q3 2019 EPS Diluted-$0.08-$0.08N/M vs Q3 2019 Operating Income-$4,508,367N/M Operating Cash Flowderived-$4,665,588N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 10, 2020 · 41 d after period end